Sarepta Therapeutics (SRPT) Net Income Growth (5y) (2015 - 2026)
Sarepta Therapeutics (SRPT) Net Income Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,380.63 Bn | 66,380.34 Bn | - |
| 2 | Nanobiotix | 1,910.39 Bn | 1,910.33 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 470.95 Bn | 466.16 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.97 Bn | 114.72 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - |
| 8 | Argenx Se | 55.76 Bn | 50.58 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.71 Bn | 1.30 Bn | 622.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.81% |
| Dec 31, 2025 | -8.36% |
| Sep 30, 2025 | 1.74% |
| Jun 30, 2025 | 27.01% |
| Mar 31, 2025 | -91.25% |
| Dec 31, 2024 | 21.74% |
| Sep 30, 2024 | 17.78% |
| Jun 30, 2024 | 15.14% |
| Mar 31, 2024 | 19.84% |
| Dec 31, 2023 | 18.36% |
| Sep 30, 2023 | 11.73% |
| Jun 30, 2023 | 26.19% |
| Mar 31, 2023 | -70.98% |
| Dec 31, 2022 | 73.50% |
| Sep 30, 2022 | -40.11% |
| Jun 30, 2022 | -29.71% |
| Mar 31, 2022 | -26.58% |
| Dec 31, 2021 | -6.69% |
| Sep 30, 2021 | 3.23% |
| Jun 30, 2021 | -5.49% |